OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/09/2026
Back to search
Official data from USPTO
NAMUPLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/10/2026
Trademark type
Word
Nice classes
5
Filing date
08/14/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
04/10/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
LAM, HAI-LY HUYNH
Law office
N10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SML Genetree Co., Ltd.
Representatives
Sang Yoon Kang Studebaker Brackett PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents for medical and veterinary use; diagnostic reagents for medical or veterinary use; diagnostic reagents for medical use; diagnostic reagents for pharmaceutical use; clinical diagnostic reagents for medical use; medical diagnostic reagents for immunological diseases; diagnostic agents for medical or veterinary use; reagents and media for medical and veterinary diagnosis; diagnostic agents for medical and veterinary use; medical pregnancy diagnostic reagents and assays for testing body fluids; medical diagnostic agents for use in the detectiontreatmentmonitoring of cancergenetic diseasesgenetic predispositionsdrug responses; diagnostic reagents for in vitro medical use; chemical reagents for medical diagnosis and analysis; chemical diagnostic agents for medical purposes used by medical laboratories; medical diagnostic agents for use in the analysis and monitoring of tumors; medical diagnostic test reagents for use in the analysis and monitoring of tumors; reagents for medical purposesfor the treatmentmonitoringdiagnosis of diseases; diagnostic radiopharmaceutical preparations and reagents for the medical analysis and identification of nucleic acidsnucleic acid sequencesinfectious agentspathogens; culture media for cultivating animal cells for veterinary use; culture media for use in blood analysis for medical purposes; cell culture media for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes
Publications
History of USPTO decisions and trademark events.
25 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/26/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2026
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/05/2026
FIMP
FINAL DISPOSITION PROCESSED
03/05/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2025
PUBO
PUBLISHED FOR OPPOSITION
06/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/28/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/05/2025
RFNT
REFUSAL PROCESSED BY IB
04/19/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2025
RFRR
REFUSAL PROCESSED BY MPU
03/29/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/24/2025
CNRT
NON-FINAL ACTION WRITTEN
02/23/2025
DOCK
ASSIGNED TO EXAMINER
02/20/2025
MAFR
APPLICATION FILING RECEIPT MAILED
10/25/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/25/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2024
Continuous trademark protection
Get notified about every new filing that threatens NAMUPLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.